ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Eluting Peripheral Stents Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-6A12457
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Drug Eluting Peripheral Stents Market Research Report 2022
BUY CHAPTERS

Global Drug Eluting Peripheral Stents Market Research Report 2025

Code: QYRE-Auto-6A12457
Report
March 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
W. L. Gore & Associates
Abbott Laboratories
Stentys SA, Cook Medical Inc.
Meril Life Sciences Pvt Ltd
Boston Scientific Corporation
iVascular SLU

Drug Eluting Peripheral Stents Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Drug Eluting Peripheral Stents Market

Drug Eluting Peripheral Stents Market

The global market for Drug Eluting Peripheral Stents was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Drug-eluting peripheral stents are medical devices used in the treatment of peripheral artery disease (PAD), a condition in which the arteries outside of the heart, particularly those in the legs, become narrowed or blocked by atherosclerotic plaques. These stents are designed to help restore blood flow in these diseased arteries and reduce the risk of restenosis, which is the re-narrowing of the blood vessels after an initial intervention.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug Eluting Peripheral Stents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Peripheral Stents.
The Drug Eluting Peripheral Stents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Eluting Peripheral Stents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Peripheral Stents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Drug Eluting Peripheral Stents Market Report

Report Metric Details
Report Name Drug Eluting Peripheral Stents Market
CAGR 5%
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boston Scientific Corporation, W. L. Gore & Associates, Abbott Laboratories, iVascular SLU., Meril Life Sciences Pvt. Ltd., Stentys SA, Cook Medical Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Drug Eluting Peripheral Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Drug Eluting Peripheral Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Drug Eluting Peripheral Stents Market report?

Ans: The main players in the Drug Eluting Peripheral Stents Market are Boston Scientific Corporation, W. L. Gore & Associates, Abbott Laboratories, iVascular SLU., Meril Life Sciences Pvt. Ltd., Stentys SA, Cook Medical Inc.

What are the Application segmentation covered in the Drug Eluting Peripheral Stents Market report?

Ans: The Applications covered in the Drug Eluting Peripheral Stents Market report are Hospitals, Specialty Clinics, Ambulatory Surgical Centers/Outpatients

What are the Type segmentation covered in the Drug Eluting Peripheral Stents Market report?

Ans: The Types covered in the Drug Eluting Peripheral Stents Market report are Carotid Artery, Iliac Artery, Infrapop Artery, Renal Artery

Recommended Reports

Peripheral Vascular Devices

Drug-Eluting Technologies

Cardiovascular Disease Therapies

1 Drug Eluting Peripheral Stents Market Overview
1.1 Product Definition
1.2 Drug Eluting Peripheral Stents by Type
1.2.1 Global Drug Eluting Peripheral Stents Market Value Comparison by Type (2024 VS 2031)
1.2.2 Carotid Artery
1.2.3 Iliac Artery
1.2.4 Infrapop Artery
1.2.5 Renal Artery
1.2.6 Carotid Artery
1.3 Drug Eluting Peripheral Stents by Application
1.3.1 Global Drug Eluting Peripheral Stents Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers/Outpatients
1.4 Global Drug Eluting Peripheral Stents Market Size Estimates and Forecasts
1.4.1 Global Drug Eluting Peripheral Stents Revenue 2020-2031
1.4.2 Global Drug Eluting Peripheral Stents Sales 2020-2031
1.4.3 Global Drug Eluting Peripheral Stents Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Drug Eluting Peripheral Stents Market Competition by Manufacturers
2.1 Global Drug Eluting Peripheral Stents Sales Market Share by Manufacturers (2020-2025)
2.2 Global Drug Eluting Peripheral Stents Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Drug Eluting Peripheral Stents Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Drug Eluting Peripheral Stents, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Eluting Peripheral Stents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Eluting Peripheral Stents, Product Type & Application
2.7 Global Key Manufacturers of Drug Eluting Peripheral Stents, Date of Enter into This Industry
2.8 Global Drug Eluting Peripheral Stents Market Competitive Situation and Trends
2.8.1 Global Drug Eluting Peripheral Stents Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drug Eluting Peripheral Stents Players Market Share by Revenue
2.8.3 Global Drug Eluting Peripheral Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug Eluting Peripheral Stents Market Scenario by Region
3.1 Global Drug Eluting Peripheral Stents Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Drug Eluting Peripheral Stents Sales by Region: 2020-2031
3.2.1 Global Drug Eluting Peripheral Stents Sales by Region: 2020-2025
3.2.2 Global Drug Eluting Peripheral Stents Sales by Region: 2026-2031
3.3 Global Drug Eluting Peripheral Stents Revenue by Region: 2020-2031
3.3.1 Global Drug Eluting Peripheral Stents Revenue by Region: 2020-2025
3.3.2 Global Drug Eluting Peripheral Stents Revenue by Region: 2026-2031
3.4 North America Drug Eluting Peripheral Stents Market Facts & Figures by Country
3.4.1 North America Drug Eluting Peripheral Stents Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Drug Eluting Peripheral Stents Sales by Country (2020-2031)
3.4.3 North America Drug Eluting Peripheral Stents Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Eluting Peripheral Stents Market Facts & Figures by Country
3.5.1 Europe Drug Eluting Peripheral Stents Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Drug Eluting Peripheral Stents Sales by Country (2020-2031)
3.5.3 Europe Drug Eluting Peripheral Stents Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Eluting Peripheral Stents Market Facts & Figures by Region
3.6.1 Asia Pacific Drug Eluting Peripheral Stents Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Drug Eluting Peripheral Stents Sales by Region (2020-2031)
3.6.3 Asia Pacific Drug Eluting Peripheral Stents Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Drug Eluting Peripheral Stents Market Facts & Figures by Country
3.7.1 Latin America Drug Eluting Peripheral Stents Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Drug Eluting Peripheral Stents Sales by Country (2020-2031)
3.7.3 Latin America Drug Eluting Peripheral Stents Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug Eluting Peripheral Stents Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Eluting Peripheral Stents Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Drug Eluting Peripheral Stents Sales by Country (2020-2031)
3.8.3 Middle East and Africa Drug Eluting Peripheral Stents Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Eluting Peripheral Stents Sales by Type (2020-2031)
4.1.1 Global Drug Eluting Peripheral Stents Sales by Type (2020-2025)
4.1.2 Global Drug Eluting Peripheral Stents Sales by Type (2026-2031)
4.1.3 Global Drug Eluting Peripheral Stents Sales Market Share by Type (2020-2031)
4.2 Global Drug Eluting Peripheral Stents Revenue by Type (2020-2031)
4.2.1 Global Drug Eluting Peripheral Stents Revenue by Type (2020-2025)
4.2.2 Global Drug Eluting Peripheral Stents Revenue by Type (2026-2031)
4.2.3 Global Drug Eluting Peripheral Stents Revenue Market Share by Type (2020-2031)
4.3 Global Drug Eluting Peripheral Stents Price by Type (2020-2031)
5 Segment by Application
5.1 Global Drug Eluting Peripheral Stents Sales by Application (2020-2031)
5.1.1 Global Drug Eluting Peripheral Stents Sales by Application (2020-2025)
5.1.2 Global Drug Eluting Peripheral Stents Sales by Application (2026-2031)
5.1.3 Global Drug Eluting Peripheral Stents Sales Market Share by Application (2020-2031)
5.2 Global Drug Eluting Peripheral Stents Revenue by Application (2020-2031)
5.2.1 Global Drug Eluting Peripheral Stents Revenue by Application (2020-2025)
5.2.2 Global Drug Eluting Peripheral Stents Revenue by Application (2026-2031)
5.2.3 Global Drug Eluting Peripheral Stents Revenue Market Share by Application (2020-2031)
5.3 Global Drug Eluting Peripheral Stents Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boston Scientific Corporation
6.1.1 Boston Scientific Corporation Company Information
6.1.2 Boston Scientific Corporation Description and Business Overview
6.1.3 Boston Scientific Corporation Drug Eluting Peripheral Stents Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boston Scientific Corporation Drug Eluting Peripheral Stents Product Portfolio
6.1.5 Boston Scientific Corporation Recent Developments/Updates
6.2 W. L. Gore & Associates
6.2.1 W. L. Gore & Associates Company Information
6.2.2 W. L. Gore & Associates Description and Business Overview
6.2.3 W. L. Gore & Associates Drug Eluting Peripheral Stents Sales, Revenue and Gross Margin (2020-2025)
6.2.4 W. L. Gore & Associates Drug Eluting Peripheral Stents Product Portfolio
6.2.5 W. L. Gore & Associates Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Company Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Drug Eluting Peripheral Stents Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abbott Laboratories Drug Eluting Peripheral Stents Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 iVascular SLU.
6.4.1 iVascular SLU. Company Information
6.4.2 iVascular SLU. Description and Business Overview
6.4.3 iVascular SLU. Drug Eluting Peripheral Stents Sales, Revenue and Gross Margin (2020-2025)
6.4.4 iVascular SLU. Drug Eluting Peripheral Stents Product Portfolio
6.4.5 iVascular SLU. Recent Developments/Updates
6.5 Meril Life Sciences Pvt. Ltd.
6.5.1 Meril Life Sciences Pvt. Ltd. Company Information
6.5.2 Meril Life Sciences Pvt. Ltd. Description and Business Overview
6.5.3 Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Product Portfolio
6.5.5 Meril Life Sciences Pvt. Ltd. Recent Developments/Updates
6.6 Stentys SA, Cook Medical Inc.
6.6.1 Stentys SA, Cook Medical Inc. Company Information
6.6.2 Stentys SA, Cook Medical Inc. Description and Business Overview
6.6.3 Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Product Portfolio
6.6.5 Stentys SA, Cook Medical Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Eluting Peripheral Stents Industry Chain Analysis
7.2 Drug Eluting Peripheral Stents Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Eluting Peripheral Stents Production Mode & Process Analysis
7.4 Drug Eluting Peripheral Stents Sales and Marketing
7.4.1 Drug Eluting Peripheral Stents Sales Channels
7.4.2 Drug Eluting Peripheral Stents Distributors
7.5 Drug Eluting Peripheral Stents Customer Analysis
8 Drug Eluting Peripheral Stents Market Dynamics
8.1 Drug Eluting Peripheral Stents Industry Trends
8.2 Drug Eluting Peripheral Stents Market Drivers
8.3 Drug Eluting Peripheral Stents Market Challenges
8.4 Drug Eluting Peripheral Stents Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
W. L. Gore & Associates
Abbott Laboratories
Stentys SA, Cook Medical Inc.
Meril Life Sciences Pvt Ltd
Boston Scientific Corporation
iVascular SLU
List of Tables
 Table 1. Global Drug Eluting Peripheral Stents Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Drug Eluting Peripheral Stents Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Drug Eluting Peripheral Stents Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Drug Eluting Peripheral Stents Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Drug Eluting Peripheral Stents Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Drug Eluting Peripheral Stents Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Drug Eluting Peripheral Stents Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Drug Eluting Peripheral Stents Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Drug Eluting Peripheral Stents, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Drug Eluting Peripheral Stents, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Drug Eluting Peripheral Stents, Product Type & Application
 Table 12. Global Key Manufacturers of Drug Eluting Peripheral Stents, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Drug Eluting Peripheral Stents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Peripheral Stents as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Drug Eluting Peripheral Stents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Drug Eluting Peripheral Stents Sales by Region (2020-2025) & (K Units)
 Table 18. Global Drug Eluting Peripheral Stents Sales Market Share by Region (2020-2025)
 Table 19. Global Drug Eluting Peripheral Stents Sales by Region (2026-2031) & (K Units)
 Table 20. Global Drug Eluting Peripheral Stents Sales Market Share by Region (2026-2031)
 Table 21. Global Drug Eluting Peripheral Stents Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Drug Eluting Peripheral Stents Revenue Market Share by Region (2020-2025)
 Table 23. Global Drug Eluting Peripheral Stents Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Drug Eluting Peripheral Stents Revenue Market Share by Region (2026-2031)
 Table 25. North America Drug Eluting Peripheral Stents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Drug Eluting Peripheral Stents Sales by Country (2020-2025) & (K Units)
 Table 27. North America Drug Eluting Peripheral Stents Sales by Country (2026-2031) & (K Units)
 Table 28. North America Drug Eluting Peripheral Stents Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Drug Eluting Peripheral Stents Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Drug Eluting Peripheral Stents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Drug Eluting Peripheral Stents Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Drug Eluting Peripheral Stents Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Drug Eluting Peripheral Stents Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Drug Eluting Peripheral Stents Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Drug Eluting Peripheral Stents Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Drug Eluting Peripheral Stents Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Drug Eluting Peripheral Stents Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Drug Eluting Peripheral Stents Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Drug Eluting Peripheral Stents Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Drug Eluting Peripheral Stents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Drug Eluting Peripheral Stents Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Drug Eluting Peripheral Stents Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Drug Eluting Peripheral Stents Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Drug Eluting Peripheral Stents Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Drug Eluting Peripheral Stents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Drug Eluting Peripheral Stents Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Drug Eluting Peripheral Stents Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Drug Eluting Peripheral Stents Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Drug Eluting Peripheral Stents Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Drug Eluting Peripheral Stents Sales (K Units) by Type (2020-2025)
 Table 51. Global Drug Eluting Peripheral Stents Sales (K Units) by Type (2026-2031)
 Table 52. Global Drug Eluting Peripheral Stents Sales Market Share by Type (2020-2025)
 Table 53. Global Drug Eluting Peripheral Stents Sales Market Share by Type (2026-2031)
 Table 54. Global Drug Eluting Peripheral Stents Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Drug Eluting Peripheral Stents Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Drug Eluting Peripheral Stents Revenue Market Share by Type (2020-2025)
 Table 57. Global Drug Eluting Peripheral Stents Revenue Market Share by Type (2026-2031)
 Table 58. Global Drug Eluting Peripheral Stents Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Drug Eluting Peripheral Stents Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Drug Eluting Peripheral Stents Sales (K Units) by Application (2020-2025)
 Table 61. Global Drug Eluting Peripheral Stents Sales (K Units) by Application (2026-2031)
 Table 62. Global Drug Eluting Peripheral Stents Sales Market Share by Application (2020-2025)
 Table 63. Global Drug Eluting Peripheral Stents Sales Market Share by Application (2026-2031)
 Table 64. Global Drug Eluting Peripheral Stents Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Drug Eluting Peripheral Stents Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Drug Eluting Peripheral Stents Revenue Market Share by Application (2020-2025)
 Table 67. Global Drug Eluting Peripheral Stents Revenue Market Share by Application (2026-2031)
 Table 68. Global Drug Eluting Peripheral Stents Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Drug Eluting Peripheral Stents Price (US$/Unit) by Application (2026-2031)
 Table 70. Boston Scientific Corporation Company Information
 Table 71. Boston Scientific Corporation Description and Business Overview
 Table 72. Boston Scientific Corporation Drug Eluting Peripheral Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Boston Scientific Corporation Drug Eluting Peripheral Stents Product
 Table 74. Boston Scientific Corporation Recent Developments/Updates
 Table 75. W. L. Gore & Associates Company Information
 Table 76. W. L. Gore & Associates Description and Business Overview
 Table 77. W. L. Gore & Associates Drug Eluting Peripheral Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. W. L. Gore & Associates Drug Eluting Peripheral Stents Product
 Table 79. W. L. Gore & Associates Recent Developments/Updates
 Table 80. Abbott Laboratories Company Information
 Table 81. Abbott Laboratories Description and Business Overview
 Table 82. Abbott Laboratories Drug Eluting Peripheral Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Abbott Laboratories Drug Eluting Peripheral Stents Product
 Table 84. Abbott Laboratories Recent Developments/Updates
 Table 85. iVascular SLU. Company Information
 Table 86. iVascular SLU. Description and Business Overview
 Table 87. iVascular SLU. Drug Eluting Peripheral Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. iVascular SLU. Drug Eluting Peripheral Stents Product
 Table 89. iVascular SLU. Recent Developments/Updates
 Table 90. Meril Life Sciences Pvt. Ltd. Company Information
 Table 91. Meril Life Sciences Pvt. Ltd. Description and Business Overview
 Table 92. Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Product
 Table 94. Meril Life Sciences Pvt. Ltd. Recent Developments/Updates
 Table 95. Stentys SA, Cook Medical Inc. Company Information
 Table 96. Stentys SA, Cook Medical Inc. Description and Business Overview
 Table 97. Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Product
 Table 99. Stentys SA, Cook Medical Inc. Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Drug Eluting Peripheral Stents Distributors List
 Table 103. Drug Eluting Peripheral Stents Customers List
 Table 104. Drug Eluting Peripheral Stents Market Trends
 Table 105. Drug Eluting Peripheral Stents Market Drivers
 Table 106. Drug Eluting Peripheral Stents Market Challenges
 Table 107. Drug Eluting Peripheral Stents Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Drug Eluting Peripheral Stents
 Figure 2. Global Drug Eluting Peripheral Stents Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drug Eluting Peripheral Stents Market Share by Type: 2024 & 2031
 Figure 4. Carotid Artery Product Picture
 Figure 5. Iliac Artery Product Picture
 Figure 6. Infrapop Artery Product Picture
 Figure 7. Renal Artery Product Picture
 Figure 8. Carotid Artery Product Picture
 Figure 9. Global Drug Eluting Peripheral Stents Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Drug Eluting Peripheral Stents Market Share by Application: 2024 & 2031
 Figure 11. Hospitals
 Figure 12. Specialty Clinics
 Figure 13. Ambulatory Surgical Centers/Outpatients
 Figure 14. Global Drug Eluting Peripheral Stents Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Drug Eluting Peripheral Stents Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Drug Eluting Peripheral Stents Sales (2020-2031) & (K Units)
 Figure 17. Global Drug Eluting Peripheral Stents Average Price (US$/Unit) & (2020-2031)
 Figure 18. Drug Eluting Peripheral Stents Report Years Considered
 Figure 19. Drug Eluting Peripheral Stents Sales Share by Manufacturers in 2024
 Figure 20. Global Drug Eluting Peripheral Stents Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Drug Eluting Peripheral Stents Players: Market Share by Revenue in Drug Eluting Peripheral Stents in 2024
 Figure 22. Drug Eluting Peripheral Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Drug Eluting Peripheral Stents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Drug Eluting Peripheral Stents Sales Market Share by Country (2020-2031)
 Figure 25. North America Drug Eluting Peripheral Stents Revenue Market Share by Country (2020-2031)
 Figure 26. United States Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Drug Eluting Peripheral Stents Sales Market Share by Country (2020-2031)
 Figure 29. Europe Drug Eluting Peripheral Stents Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Drug Eluting Peripheral Stents Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Drug Eluting Peripheral Stents Revenue Market Share by Region (2020-2031)
 Figure 37. China Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Drug Eluting Peripheral Stents Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Drug Eluting Peripheral Stents Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Drug Eluting Peripheral Stents Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Drug Eluting Peripheral Stents Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Drug Eluting Peripheral Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Drug Eluting Peripheral Stents by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Drug Eluting Peripheral Stents by Type (2020-2031)
 Figure 58. Global Drug Eluting Peripheral Stents Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Drug Eluting Peripheral Stents by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Drug Eluting Peripheral Stents by Application (2020-2031)
 Figure 61. Global Drug Eluting Peripheral Stents Price (US$/Unit) by Application (2020-2031)
 Figure 62. Drug Eluting Peripheral Stents Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Peripheral Drug Eluting Stent Market Research Report 2025
Global Peripheral Intervention Drug Eluting Devices Market Insights Forecast to 2030
Drug Eluting Stent System Market
Global Implantable Drug Eluting Stent Market Research Report 2024
Global Implantable Coronary Drug Eluting Stent Market Research Report 2024
Global Peripheral Stents Market Research Report 2024
Global Peripheral Self expanding Stent Market Research Report 2024
Global Peripheral Intervention Devices Market Insights Forecast to 2030
Global Drug Eluting Coronary Stent System Market Research Report 2024
Global Peripheral Metal Stent Market Research Report 2024
Global Peripheral Arterial Disease Diagnostics Market Research Report 2025
Global Peripheral Stent Graft System Market Research Report 2024
Global Peripheral Vascular Devices Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Drug Eluting Coronary Stent Market Research Report 2025
Global Peripheral Arterial Interventional Devices Market Research Report 2025
Global Peripheral Stent Systems Market Research Report 2024
Global Self Expanding Peripheral Stent System Market Research Report 2024
Global Peripheral Vascular Interventional Devices Market Research Report 2024
Global Interventional Cardiology and Peripheral Vascular Devices Market Research Report 2025
Global Coronary Drug Stent System Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions